Allergan, Inc.

Allergan Sales, Inc.

Other

Yariv Donde

Robert M Burk

Jeremiah H Nguyen

Michael E Garst

David W Old

John E Donello

Daniel W Gil

Wha-Bin Im

Mark Holoboski

Karen M Kedzie

David Frederick Woodward

Mari F Posner

Achim H Krauss

Brent A Johnson

Larry Allen Wheeler

June Chen

Yanbin Liang

Achim H-p Krauss

Mark Holobiski

Disclosed herein is a compound of the formula Therapeutic methods, compositions, and medicaments, related thereto are also disclosed.

Substituted arylcyclopentenes as therapeutic agents

Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I wherein X, Y, B, R, R, R, R, Rand n have the meanings found herein.

Treatment of inflammatory bowel disease

The invention provides ester compounds for treating ophthalmic diseases. The esters of the invention are particularly advantageous due to their stability in aqueous solutions.

Amidoalkylenyl and amidoaryl esters, compositions thereof, and methods for their use

The invention provides compositions and methods for wound healing and scar reduction. The compositions and methods of the invention include at least one EP4 agonist set forth herein. Wounds and or scars that can be treated by the compositions and methods of the invention can arise from events such as surgery, trauma, disease, mechanical injury, burn, radiation, poisoning, and the like.

Compounds and methods for skin repair

Described herein are compounds which can be used in topical liquids, creams, or other dosage forms such as solids, for reducing intraocular pressure, treating glaucoma, growing hair, treating wounds, or other medical and/or cosmetic uses.

Therapeutic prostaglandin receptor agonists

Disclosed herein are compounds having a formula: Therapeutic methods, medicaments, and compositions related thereto are also disclosed.

Substituted cyclopentanes having prostaglandin activity

Disclosed herein are compounds having a formula: or a pharmaceutically acceptable salt thereof, as well as therapeutic methods, medicaments, and compositions related thereto.

Substituted cyclopentenes as therapeutic agents

Geminal dialkyl prostanoids

A compound comprising  Also disclosed herein are compounds comprising  Also disclosed herein are methods of treating diseases or conditions, including glaucoma and elevated intraocular pressure. Compositions and methods of manufacturing medicaments related thereto are also disclosed.

Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents

Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein B, Y, and A are as described.Methods, compositions, and medicaments related thereto are also disclosed.

Therapeutic cyclopentane derivatives

Disclosed herein are compounds represented by the formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.

Growing community of inventors

Dana Point, CA, United States of America

Yariv Donde